Gemita Injection contains Gemcitabine 200 mg, a chemotherapy medication used in the treatment of various types of cancer, including non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian cancer, and bladder cancer. It is an antimetabolite that interferes with the DNA synthesis of cancer cells, thereby inhibiting their growth and proliferation.

• Effective in treating a range of solid tumors

• Slows or halts cancer cell replication

• Used as first-line or combination therapy in several cancers

• Can improve survival and quality of life in cancer patients

• Administered intravenously (IV) by a healthcare professional

• Infused over a 30-minute period

• Dosing schedule depends on cancer type, stage, and patient response

• Patients must stay hydrated and follow medical instructions during treatment

• Strength: 200 mg Gemcitabine per vial

• Form: Lyophilized powder for reconstitution

• Route: Intravenous injection

• Frequency: As prescribed by an oncologist (usually once weekly or on specific days of a treatment cycle)

• Strictly for hospital or clinic administration under medical supervision

• Not recommended during pregnancy or breastfeeding

• Regular blood tests are required to monitor white blood cell and platelet counts

• Use with caution in patients with liver or kidney impairments

• Inform your doctor about all other medications and health conditions

• Common: Nausea, vomiting, fatigue, low blood counts, fever

• Less common: Rash, flu-like symptoms, liver enzyme elevation

• Serious: Pulmonary toxicity, kidney dysfunction, allergic reactions

• Seek immediate medical attention for breathing difficulty, bleeding, or severe infection

• Store below 25°C, protected from light

• Reconstituted solution should be used promptly or stored under conditions specified by the manufacturer

• Keep out of reach of children and unauthorized personnel

Q1. What is Gemita Injection used for?
A: It’s used to treat several cancers including lung, pancreatic, breast, ovarian, and bladder cancers.

Q2. Can it be taken orally?
A: No, Gemita is for intravenous use only and must be administered in a medical setting.

Q3. What precautions should I take during treatment?
A: Avoid crowds and infections, report any signs of fever or unusual bleeding, and follow your oncologist’s instructions.

Q4. Can it cause hair loss?
A: Hair loss is not very common with Gemcitabine, but fatigue and low blood counts are.

Q5. How is the dose determined?
A: Based on your body surface area (BSA), blood test results, and type of cancer.